ACE inhibitor pathway (WP396)

Mus musculus

The renin-angiotensin-aldosterone system (RAAS) is central to the control of blood pressure and the target of several types of anti-hypertensive drugs. This pathway depicts a simplified representation of the pharmacodynamics (PD) of RAAS-acting drugs including candidate genes for the pharmacogenomics (PGx) of ACE inhibitors, angiotensin receptor blockers (ARBs), renin inhibitor aliskiren and aldosterone receptor antagonists. Source: PharmGKB (


Caroline F. Thorn , Kristina Hanspers , Thomas Kelder , Egon Willighagen , Christine Chichester , and Eric Weitz


last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.


Mus musculus



Pathway Ontology

ACE inhibitor drug pathway


Label Type Compact URI Comment
Bradykinin Metabolite hmdb:HMDB0004246
Angiotensin II Metabolite hmdb:HMDB0001035
Aldosterone Metabolite kegg.compound:C01780
Angiotensin I Metabolite pubchem.compound:3081372
ACE Inhibitor Metabolite chebi:35457
Ace GeneProduct ncbigene:11421
Kng1 GeneProduct ncbigene:16644
Agtr2 GeneProduct ncbigene:11609
Ace GeneProduct ncbigene:11421
Agtr1 GeneProduct ncbigene:11607
Ren1 GeneProduct ncbigene:19701
Nos3 GeneProduct ncbigene:18127
Agt GeneProduct ncbigene:11606
Bdkrb2 GeneProduct ncbigene:12062


  1. The emerging role of ACE2 in physiology and disease. Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus ADME, et al. J Pathol. 2007 May;212(1):1–11. PubMed Europe PMC Scholia